ARCA biopharma

NASDAQ ABIO
$4.00 0.0000 0.0000%
Today share price
米国
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Показатель: 18 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

58.00M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

20.65M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

2.64
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

14.50M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

135.29 %

Upcoming events ARCA biopharma

All events
No upcoming events scheduled

Stock chart ARCA biopharma

Stock analysis ARCA biopharma

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

-10.58 28.62
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

1.57 4.29
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

-2.62 9.93
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

4.74 0.65
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

-15.60 7.67

Price change ARCA biopharma per year

2.68$ 5.50$
Min Max

Summary analysis ARCA biopharma

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure ARCA biopharma

Revenue and net income ARCA biopharma

All parameters

About company ARCA biopharma

ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase 2 clinical trial for the treatment of diseases caused by ribonucleic acid viruses initially focusing on COVID-19; and Gencaro (bucindolol hydrochloride), a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase 2 trial for the treatment of atrial fibrillation in patients with chronic heart failure (HF). The company also engages in the development of AB171, a thiol-containing derivative isosorbide mononitrate for the treatment of HF and peripheral arterial disease. ARCA biopharma, Inc. is headquartered in Westminster, Colorado.
Address:
10170 Church Ranch Way, Westminster, CO, United States, 80021
Company name: ARCA biopharma
Issuer ticker: ABIO
ISIN: US00211Y5069
Country: 米国
Exchange: NASDAQ
Currency: $
IPO date: 1997-08-08
Sector: Healthcare
Industry: Biotechnology
Site: https://www.arcabio.com

On which stock exchange are ARCA biopharma (ABIO) stocks traded?

ARCA biopharma (ABIO) stocks are traded on NASDAQ.

What is the ticker of ARCA biopharma stocks (ABIO)?

The stock ticker of ARCA biopharma’s stocks or in other words, the code is ABIO. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does ARCA biopharma (ABIO) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, ARCA biopharma (ABIO) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are ARCA biopharma (ABIO) stocks traded?

ARCA biopharma (ABIO) stocks are traded on the NASDAQ exchange in dollars.

What is the price of ARCA biopharma (ABIO) stocks today?

The current price of ARCA biopharma stocks on 18.05.2024 is 4 dollars. per share.

What is the dynamics of ARCA biopharma (ABIO) stocks from the beginning of the year?

ARCA biopharma (ABIO) quotes have increased by 138.38% from the beginning of the year up to 4 dollars. per 1 stocks.

How much did ARCA biopharma (ABIO) stocks increase in мае 2024?

This month ARCA biopharma (ABIO) quotes have increased by 23.08% to 4 dollars. per share.

How much are ARCA biopharma (ABIO) stocks worth?

Today, on October, 18.05.2024 ARCA biopharma’s (ABIO) stocks cost 4 dollars..

What is the market capitalization of ARCA biopharma (ABIO)?

Capitalization is the market value of ARCA biopharma (ABIO) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 18.05.2024, the market capitalization of ARCA biopharma (ABIO) is estimated at about 58004572 dollars.